LabConnect Accepted into the 2025 Climate Ambition Accelerator by the UN Global Compact

Johnson City, TN, March 19, 2025 – LabConnect is proud to announce its acceptance into the prestigious 2025 cohort of the Climate Ambition Accelerator, a six-month program led by the United Nations Global Compact. This achievement underscores LabConnect’s unwavering commitment to setting Science Based Targets (SBTs) for greenhouse gas (GHG) reduction and advancing our overall sustainability strategy.

The Climate Ambition Accelerator is designed to equip companies with the knowledge and skills necessary to accelerate progress towards setting science-based emissions reduction targets aligned with the 1.5℃ pathway, ultimately setting them on a path towards net-zero emissions by 2050.

Through this program, LabConnect will share access to global best practices, peer-to-peer learning opportunities, practical activities, capacity building sessions, and on-demand training.

“Being part of the Climate Ambition Accelerator is a significant milestone for LabConnect,” said Ben Worley, Senior Director, Sustainability & ESG at LabConnect. “This opportunity aligns perfectly with our commitment to sustainability and our goal to set and achieve Science Based Targets for GHG reduction. We are excited to collaborate with other forward-thinking companies and leverage the resources provided by the UN Global Compact to drive meaningful climate action.”

LabConnect’s participation in the Climate Ambition Accelerator is a testament to our dedication to sustainability and our proactive approach to addressing climate change. We look forward to the insights and advancements this program will bring to our sustainability efforts.

For more information about LabConnect’s sustainability initiatives, please visit www.labconnect.com/esg.

About LabConnect

LabConnect is the world’s most agile central laboratory solutions partner, providing technology-driven, customized, orchestrated, and scalable support services for clinical trials of all sizes and complexity. With over 20 years experience and 1,900+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations.

With modern operations and strategic alliances with world-leading laboratories, LabConnect is uniquely positioned to provide access to the latest innovation and automation. LabConnect delivers exceptional service with a comprehensive suite of central laboratory solutions including custom lab kits, advanced sample tracking and integrated logistics, global standardized sample processing, industry-leading testing menu of 10,200+ validated assays, worldwide support for radiopharmaceuticals, and next-generation biorepository.

LabConnect scientific experts support pre-clinical and clinical studies with scientific project management, bioanalytical and biospecimen management, biomarker strategy and logistics solutions. LabConnect excels at data management, integrating complex datasets from diverse sources into a single, cohesive, submission-ready dataset.

Follow LabConnect on LinkedIn
Learn more at www.labconnect.com